Clinical Trials Browser

Phase 2 × INDUSTRY × etoposide phosphate × Clear all

NCT03407144 2026-02-19

MK-3475-667

Phase 2 Active not recruiting

Hodgkin Disease

NCT04924101 2025-07-23

KEYNOTE-B99

Phase 2 Completed

Parkinson Disease 4, Autosomal Dominant Lewy Body, Small Cell Lung Carcinoma

NCT00191139 2010-02-17

Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

64 enrolled 13 charts

Carcinoma, Non-Small-Cell Lung